Effect of Revival Soy on Weight Loss and Skin, Hair, and Nails in Premenopausal Women
NCT ID: NCT00352157
Last Updated: 2009-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2006-07-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Dietary Soy Protein on Facial Wrinkles in Postmenopausal Women
NCT04871750
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
NCT04065035
Autologous Adipose Cells Therapy
NCT06869252
Evaluation of Soy Isoflavones on Skin Ageing Parameters
NCT06047145
A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation
NCT06629792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Improve the health and appearance of the skin by normalizing skin pigmentation and reducing wrinkles,
* Improve the health and appearance of hair by enhancing sheen and ease of combing, and
* Improve the health and appearance of nails by enhancing shine, flexibility, and strength.
* Stimulate a loss in weight and a reduction in the Body Mass Index (BMI),
For this study, obese (BMI = 30-40 kg/m2) premenopausal women (25-45 years of age) with mild to moderate photoaging (n=40) will receive either a Revival® soy shake (20 grams soy protein with 160 mg total isoflavones; n=20) or a placebo shake (20 grams of milk protein with 0 mg isoflavones; n=20) daily for 6 months. The subjects will be asked to come into the office for a total of seven visits, at baseline and at monthly intervals for 6 months. At baseline, month 3, and month 6, the subjects will be asked to complete a questionnaire in order to provide self-reported improvements related to hair, skin, and nail health. Following completion of the questionnaire, the investigator and the dermatology clinic staff will examine the subjects to assess the health and appearance of their skin, hair, and nails at baseline, month 3, and month 6.
After acceptance into the study, a registered dietitian will instruct the study subjects in the use of a low-energy (1,200 - 1,500 kcal/day) diet that incorporates 2 soy-based daily meal replacements (shakes, \~500 kcal), a minimum of 5 daily servings of fruits and vegetables (\~300 kcal), and one entrée (\~400 - 500 kcal). Subjects will be required to keep a dietary food intake record of all food and supplement use during the trial. Anthropometric data (height, body weight, waist circumference and hip circumference) will be collected at baseline and at monthly intervals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Revival Soy Dietary Supplement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 25-45 years.
* BMI between 30 - 40 kg/m2.
* Motivated to lose weight.
* Subjects must be in general good health as determined from a medical history.
* Subjects must have mild to moderate photoaging.
* Subjects must use a shampoo from the approved list without change for the entire duration of the study.
* Must not be consuming soy supplements or other soy products currently.
* Must not be pregnant (negative pregnancy test at screening) and agree not to become pregnant during the course of the study.
* Subjects must read and sign the informed consent form after the nature of the study has been fully explained.
Exclusion Criteria
* Subjects who are required to spend excessive time in the sun (i.e. lifeguards, other outdoor workers).
* Subjects who are currently participating or have participated within the last 4 weeks in any other clinical study (i.e., dermal patch, use tests, investigational drug or devices, etc.).
* Subjects viewed by the investigator as not being able to complete the study.
* Subjects who are unwilling to leave all of their current skin care products unchanged for the 6 months of the study.
* Subjects who are unwilling to leave all of their current nail care products unchanged for the 6 months of the study.
* Subjects who are unwilling to leave all of their current oral medications unchanged for the 6 months of the study.
* Subjects who have experienced large variations in body weight during the previous 3 months
* Subjects currently using other weight loss medications or supplements.
* Subjects who had surgical intervention for the treatment of obesity.
25 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dermatology Consulting Services, High Point NC
OTHER
Physicians Pharmaceuticals, Inc.
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zoe D Draelos, M.D.
Role: PRINCIPAL_INVESTIGATOR
Dermatology Consulting Services, High Point NC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology Consulting Services
High Point, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCS-61-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.